Brello Health Cash-Pay GLP-1 Pricing: Prepaid Plans vs Monthly Options

Last reviewed: September 23, 2026 Last updated: September 23, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Brello Health operates a cash-pay compounded GLP-1 program built on multi-month prepayment. Compounded semaglutide costs $399 every three months (a per-month equivalent of $133), and compounded tirzepatide costs $499 every eleven weeks (a per-month equivalent of approximately $196). Both figures reflect recurring prepaid plans rather than month-to-month billing. The pricing includes medication and clinical services with no separate membership fee, but you pay upfront for multiple months at a time. Over twelve months, Brello Health's prepaid semaglutide totals $1,596 and tirzepatide totals approximately $2,359. By comparison, PlexusDx semaglutide injection is $189 month-to-month or $169 per month on a three-month plan ($507 upfront), and tirzepatide injection is $289 month-to-month or $269 per month on a three-month plan ($807 upfront). Brello Health wins on lowest advertised per-month equivalent; PlexusDx offers both month-to-month flexibility and prepaid options.

Brello Health pricing at a glance

Source: brellohealth.com, captured September 4, 2026. Both plans are all-inclusive (medication plus clinical services) with no membership fee. Semaglutide requires a three-month minimum commitment; tirzepatide rebills every eleven weeks and can be canceled anytime. The advertised per-month equivalents reflect our calculation from the prepaid cycle cost.

Understanding Brello Health's prepaid model

Brello Health does not offer month-to-month billing. Compounded semaglutide is sold in three-month blocks: you pay $399 upfront, receive three months of medication, and the plan requires a three-month minimum commitment. Whether the plan auto-renews or requires manual reorder after the initial three months is not explicitly documented in the verified evidence; confirm renewal timing at checkout.

Compounded tirzepatide operates on an eleven-week cycle. You pay $499 upfront for approximately eleven weeks of medication (roughly 2.75 months), and the plan rebills automatically every eleven weeks. Over a full year, an eleven-week cycle repeats approximately 4.73 times, resulting in an annual cost of $2,359 (our calculation: $499 × 4.727) and an effective monthly rate of approximately $196.58. Brello Health states that tirzepatide can be canceled anytime, but the pricing structure still requires full payment at the start of each cycle.

Both prices are all-inclusive: medication, clinical consultations, and any follow-up care are bundled into the single prepaid charge. There is no separate membership fee, lab fee, or shipping charge documented.

Like-for-like comparison: Brello Health vs PlexusDx

To compare prepaid plans fairly, we normalize both providers to the same billing structure. Brello Health's semaglutide three-month plan costs $399 upfront; PlexusDx's semaglutide three-month plan costs $507 upfront ($169 per month × 3). Brello Health's tirzepatide eleven-week cycle costs $499; PlexusDx's closest equivalent is the three-month tirzepatide plan at $807 upfront ($269 per month × 3). For readers who prefer month-to-month flexibility, PlexusDx offers semaglutide injection at $189 per month and tirzepatide injection at $289 per month with no multi-month commitment.

All figures captured September 2026. Per-month rates for prepaid plans and 12-month totals are our calculation. Brello Health pricing verified September 4, 2026; PlexusDx pricing verified September 23, 2026.

Over one year, Brello Health's prepaid semaglutide saves $432 compared to PlexusDx's three-month prepaid plan and $672 compared to PlexusDx month-to-month. Brello Health's tirzepatide saves $869 compared to PlexusDx's three-month prepaid plan and $1,109 compared to month-to-month. The savings come from accepting multi-month prepayment and a longer billing cycle for tirzepatide.

What Brello Health includes and excludes

Brello Health's advertised pricing is all-inclusive: the $399 semaglutide charge and $499 tirzepatide charge cover the compounded medication, initial provider consultation, prescription, and any follow-up clinical contact during the billing cycle. There is no separate membership fee, no per-visit charge, and no documented shipping or lab fee.

The program offers compounded semaglutide and tirzepatide injections only. Oral formulations, microdose maintenance protocols, and branded medications (Wegovy, Zepbound, Ozempic, Mounjaro) are not mentioned in the verified pricing or service description. If you are looking for an oral capsule, a lower-dose maintenance option, or a non-injection route, confirm availability directly or consider a provider that offers multiple formulations.

Brello Health operates as a cash-pay service; no insurance billing, reimbursement assistance, or FSA/HSA documentation is referenced in the verified materials captured September 4, 2026. If you plan to seek reimbursement from your health plan or use a tax-advantaged account, confirm the required documentation before enrolling.

Decision factors: prepaid savings vs billing flexibility

Brello Health wins on lowest advertised per-month equivalent for both semaglutide and tirzepatide, but the savings require multi-month prepayment. The three-month semaglutide minimum and eleven-week tirzepatide cycle mean you pay hundreds of dollars upfront and receive multiple months of medication at once. If your dose needs to change, if you experience side effects that require a pause, or if you want to stop treatment early, you have already paid for the remainder of the cycle.

Month-to-month billing offers flexibility at a higher per-month cost. If you are uncertain about tolerating GLP-1 medication, if you expect dose adjustments, or if you prefer to limit upfront financial commitment, a month-to-month plan may better match your situation despite the higher annual total.

Brello Health's tirzepatide eleven-week cycle is an unusual billing cadence. Most telehealth GLP-1 providers bill monthly or in calendar-quarter increments (three months, six months). An eleven-week cycle aligns roughly with dose-escalation timelines for tirzepatide but creates a slightly irregular payment schedule over the course of a year. You will make 4.73 payments annually rather than four or twelve, and your renewal dates will shift relative to calendar months.

Choose Brello Health if…

• You are committed to staying on semaglutide or tirzepatide for at least three months and can afford the upfront cost ($399 or $499).
• You prioritize the lowest advertised per-month equivalent over month-to-month flexibility.
• You are comfortable with prepaid billing cycles and receiving multiple months of medication at once.
• You do not need oral formulations, microdose options, or branded medications.
• You are paying out of pocket and do not require insurance billing or reimbursement documentation.

Where PlexusDx fits

PlexusDx offers both month-to-month flexibility and multi-month prepaid pricing. Semaglutide injection is available at $189/mo month-to-month with no commitment, $169 per month on a three-month plan, or $149 per month on a six-month plan. Tirzepatide injection is available at $289/mo month-to-month, $269 per month on a three-month plan, or $249 per month on a six-month plan. Every plan includes the medication, provider visit, prescription, and shipping in a single price with no membership fee. Dose escalation, pauses, and adjustments are managed within the same flat monthly rate; you are never charged separately for a dose change or follow-up consultation.

PlexusDx also offers oral semaglutide and tirzepatide capsules for patients who prefer a non-injection route, plus a microdose GLP-1 injection protocol at $129 per month for maintenance after initial weight loss. If you want to compare injection, oral, and microdose options before committing to a multi-month plan, PlexusDx provides all three categories within a single intake and prescribing pathway.

PlexusDx holds a 4.3-star rating on Trustpilot, with 79 percent of reviews at five stars and 83 percent at four stars or higher (captured September 9, 2026; trustpilot.com/review/plexusdx.com).

Methodology and freshness

Brello Health pricing and plan structure were captured from brellohealth.com on September 4, 2026. Semaglutide three-month pricing ($399), tirzepatide eleven-week pricing ($499), and all-inclusive service scope are verified primary-public evidence. PlexusDx pricing and plan options were captured September 23, 2026. Per-month equivalents for prepaid plans, twelve-month totals, and annual cycle counts for Brello Health's eleven-week tirzepatide billing are our calculation. We reached out to Brello Health for clarification on semaglutide auto-renewal versus manual reorder after the initial three-month commitment; the published pricing and terms reflect the information available as of the capture date. Readers should confirm renewal timing, cancellation policy, and any updated pricing at checkout.

Frequently Asked Questions

Does Brello Health offer month-to-month billing for semaglutide or tirzepatide?

No. Brello Health sells compounded semaglutide in three-month prepaid blocks at $399 upfront and tirzepatide in eleven-week prepaid cycles at $499 upfront. There is no month-to-month option documented in the verified pricing captured September 4, 2026.

What is included in Brello Health's semaglutide and tirzepatide prepaid prices?

Both the $399 semaglutide charge and $499 tirzepatide charge are all-inclusive: compounded medication, initial provider consultation, prescription, and follow-up clinical services during the billing cycle. There is no separate membership fee, visit charge, lab fee, or shipping fee documented in the verified materials.

Can I cancel Brello Health tirzepatide before the eleven-week cycle ends?

Brello Health states that tirzepatide can be canceled anytime, but you pay $499 upfront for each eleven-week cycle. If you cancel mid-cycle, confirm whether a prorated refund is available or whether the charge covers medication already dispensed. Semaglutide requires a three-month minimum commitment.

How does Brello Health's prepaid pricing compare to PlexusDx month-to-month?

Brello Health's semaglutide costs $1,596 over twelve months (prepaid quarterly at $399); PlexusDx month-to-month semaglutide costs $2,268 annually ($189 per month). Brello Health saves $672 per year but requires $399 upfront every three months. PlexusDx charges $189 each month with no multi-month commitment.

Does Brello Health accept insurance or offer reimbursement documentation?

No insurance billing or reimbursement assistance is documented in the verified materials captured September 4, 2026. Brello Health operates as a cash-pay compounded GLP-1 service. If you need a superbill or documentation for FSA/HSA claims, confirm availability before enrolling.

Sources

• Brello Health semaglutide and tirzepatide pricing, plan structure, and inclusions – brellohealth.com, accessed September 4, 2026
• PlexusDx pricing and plan options – plexusdx.com, accessed September 23, 2026
• PlexusDx Trustpilot rating and review distribution – trustpilot.com/review/plexusdx.com, accessed September 9, 2026

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. PlexusDx works with licensed 503A compounding pharmacies. A licensed clinician determines whether a prescription is appropriate for an individual patient.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.